Amgen (AMGN) Change in Cash (2009 - 2026)

Amgen (AMGN) has reported Change in Cash for 18 consecutive years, with $2.9 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash rose 191.97% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $3.2 billion (up 459.47% YoY), while the FY2025 annual figure was -$2.8 billion, down 376.38% from the prior year.
• Change in Cash came in at $2.9 billion for Q1 2026 at Amgen, up from -$316.0 million in the prior quarter.
• The five-year high for Change in Cash was $23.9 billion in Q1 2023, with the low at -$23.8 billion in Q4 2023.
• Average Change in Cash over 5 years is $238.2 million, with a median of -$316.0 million recorded in 2025.
• The largest YoY upside for Change in Cash was 1737.99% in 2023 against a maximum downside of 1170.53% in 2023.
• Year by year, Change in Cash stood at -$1.9 billion in 2022, then plunged by 1170.53% to -$23.8 billion in 2023, then surged by 112.45% to $3.0 billion in 2024, then plunged by 110.67% to -$316.0 million in 2025, then surged by 1020.57% to $2.9 billion in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $2.9 billion, -$316.0 million, and $1.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.